1. Meisel A, Kuczewski M. Legal myths about informed consent. Arch Intern Med 1996;156(22):2521–2526.
2. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA 1992;267:2221–2226.
3. President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Making health care decisions. Washington, DC: U.S. Government Printing Office, 1982.
4. Brock DW. Life and death. New York: Cambridge University Press, 1993:21–54.
5. Berg JW, Lidz CW, Appelbaum PS. Informed consent: legal theory and clinical practice, 2nd ed. New York: Oxford University Press, 2001.
6. Schloendorff v. Society of New York Hospitals. 211 N.Y. 125, 105 N.E. 92, 1914.
7. Shultz MM. From informed consent to patient choice: a new protected interest. Yale Law J 1985;95:219–299.
8. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med 1978;299:307–401.
9. Slevin ML, Stubbs L, Plant HJ, et al. Attitudes toward chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Br Med J 1990;300:1458–1460.
10. Kassirer JP. Incorporating patient preferences into medical decisions. N Engl J Med 1994;330:1895–1896.
11. Appelbaum PS, Lidz CW, Meisel A. Informed consent: legal theory and clinical practice. New York: Oxford University Press, 1987.
12. Cassileth BR, Zupkis RV, Sutton-Smith K, et al. Information and participation preferences among cancer patients. Ann Intern Med 1980;92:832–836.
13. Lo B, Steinbrook RL, Coates T, et al. Voluntary HIV screening: weighing the benefits and harms. Ann Intern Med 1989;110:727–733.
14. Truman v. Thomas. 27 Cal.3d 285, 165 Cal.Rptr. 308, 611 P.2d 902 (Cal. 1980).
15. Howard v. University. 172 N.J. 537, 800 A.2d 73 (N.J. 2002).
16. Braddock CH III, Edwards KA, Hasenberg NM, et al. Informed decision making in outpatient practice: time to get back to basics. JAMA 1999;282(24):2313–2320.
17. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004;140(1):54–59.
18. Rozovsky FA. Consent to treatment: a practical guide, 2nd ed. Boston: Little, Brown and Company, 1990:721–727.
19. Braddock CH, Fihn SD, Levinson W, et al. How doctors and patients discuss routine clinical decisions: informed decision making in the outpatient setting. J Gen Intern Med 1997;12:339–345.
20. Diem SJ. How and when should physicians discuss clinical decisions with patients? J Gen Intern Med 1997;12:397–398.
21. Faden RR, Beauchamp TL. A history and theory of informed consent. New York: Oxford University Press, 1986:337–381.
22. Cassileth BR, Zupkis RV, Sutton-Smith K, et al. Informed consent – why are its goals imperfectly realized? N Engl J Med 1980;302:896–900.
23. Grundner TM. On the readability of surgical consent forms. N Engl J Med 1980;302:900–902.
24. Lidz CW, Meisel A, Osterweis M, et al. Barriers to informed consent. Ann Intern Med 1983;99:539–543.
25. Wu WC, Pearlman RA. Consent in medical decision-making: the role of communication. J Gen Intern Med 1988;3:9–14.
26. Strull WM, Lo B, Charles G. Do patients want to participate in decision making? JAMA 1984;252:2990–2994.
27. Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision-making? Arch Intern Med 1996;156:1414–1420.
28. Mazur DJ, Hickam DH. Patients’ preferences for risk disclosure and role in decision making for invasive medical procedures. J Gen Intern Med 1997;12:114–117.
29. Appelbaum PS, Roth LH. Patients who refuse treatment in medical hospitals. JAMA 1983;250:1296–1301.
30. Rozovsky FA. Consent to treatment: a practical guide, 2nd ed. Boston: Little, Brown and Company, 1990:24–29.
31. Annas GJ. Informed consent, cancer, and truth in prognosis. N Engl J Med 1994;330:223–225.
32. Annas GJ, Law SA, Rosenblatt RA, et al. American health law. Boston: Little, Brown and Company, 1990: 601–612.
33. Canterbury v. Spence. 464 F.2d 772 (D.C. Cir. 1972).
34. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA 2004; 291(19):2359–2366.
35. Barry MJ, Fowler FJ, Mulley AG, et al. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 1995;33:771–782.
36. McNeil BJ, Pauker SG, Sox H, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med 1982;306:1259.
37. Brody H. The healer’s power. New Haven: Yale University Press, 1992.
38. Protheroe J, Fahey T, Montgomery AA, et al. The impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. Br Med J 2000;320(7246):1380–1384.
39. Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Br Med J 2001;323(7323):1218–1222.
40. Ingelfinger FJ. Arrogance. N Engl J Med 1980;303:1507–1511.
41. Quill TE, Brody H. Physician recommendations and patient autonomy: finding a balance between physician power and patient choice. Ann Intern Med 1996;126:763–769.
42. Ubel PA. “What should I do, doc?”: Some psychologic benefits of physician recommendations. Arch Intern Med 2002;162(9):977–980.